河合 秀樹

Medicine & Life Sciences

1. Acute Coronary Syndrome 41%
2. Acute Kidney Injury 15%
3. Angioscopy 14%
4. Annexin A5 16%
5. Anomalous Left Coronary Artery 13%
6. Apoptosis 12%
7. Atrial Fibrillation 20%
8. Brain Natriuretic Peptide 38%
9. Carotid Arteries 17%
10. Carotid Endarterectomy 10%
11. Chronic Renal Insufficiency 11%
12. Computed Tomography Angiography 100%
13. Coronary Angiography 28%
14. Coronary Artery Disease 32%
15. Coronary Sinus 10%
16. Coronary Stenosis 12%
17. Coronary Vessels 46%
18. Coronavirus 11%
19. duramycin 36%
20. Echocardiography 17%
21. Eicosapentaenoic Acid 22%
22. Fatty Acid-Binding Proteins 23%
23. fibrin fragment D 28%
24. Genetic Testing 11%
25. Glomerular Filtration Rate 10%
26. Heart Failure 15%
27. HSP72 Heat-Shock Proteins 13%
28. Intensive Care Units 15%
29. Molecular Imaging 21%
30. Mortality 13%
31. Mucocutaneous Lymph Node Syndrome 11%
32. Myocardial Infarction 21%
33. Myocardial Ischemia 12%
34. Myocardial Perfusion Imaging 25%
35. Omega-3 Fatty Acids 11%
36. Optical Coherence Tomography 18%
37. Pathologic Constriction 31%
38. phosphatidylethanolamine 15%
39. Reperfusion 12%
40. Reperfusion Injury 17%
41. Rivaroxaban 24%
42. Sarcoidosis 20%
43. Spinocerebellar Ataxias 12%
44. Stents 16%
45. Stroke Volume 22%
46. technetium 99m HYNIC-duramycin 12%
47. Tomography 38%
48. Troponin 10%
49. Troponin I 16%
50. Warfarin 11%